Visibility Vol 11 Issue 3 & 4, 2017


Perceived Stress, Depression, and Anti-VEGF Treatment Status in People with Age-Related Macular Degeneration


AMD is known to be associated with increased emotional distress and depression and reduced quality of life. Potential sources of stress for an individual who requires anti-VEGF may include facing the prospect of uncertain visual outcomes and severe, permanent vision loss. They also often experience rapid declines in vision which can have serious negative consequences for their daily lives. Additionally, an intraocular injection may, itself, be a source of stress. There is mixed evidence regarding the relationships among anxiety, depression, and anti-VEGF treatment stage in patients with AMD. The purpose of this study was to compare perceived stress and depression levels in patients undergoing anti-VEGF treatment for AMD to those with AMD who were only being monitored.

Read More
photo of

Assessment of online patient education materials designed for people with age-related macular degeneration

Jennifer Fortuna, PhD, OTR/L; Linda Shuster, PhD, CCC-SLP, F-ASHA; Anne Riddering, PhD, OTR/L, CLVT, COMS; Cassie Lopez-Jeng, PhD, MPH, CPH, CHES

View Article
photo of

Minding the Gap: Determining Causes for Missed Low Vision Referrals to Develop a Streamlined, Sustainable Low Vision Rehabilitation System in Wisconsin

Katherine Dalzotto MD; Mark Banghart MS; Christina Thomas-Virnig PhD; Sanbrita Mondal OD

View Article
photo of

Assessment of Modified Patient Education Materials for People with Age-Related Macular Degeneration

Jennifer Fortuna, PhD, OTR/L; Linda Shuster, PhD, CCC-SLP, F-ASHA; Anne Riddering, PhD, OTR/L, CLVT, COMS; Cassie Lopez-Jeng, PhD; MPH, CPH, CHES

View Article